Cabaletta Bio, Inc. (CABA)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Cabaletta Bio, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Cabaletta Bio, Inc. (CABA) has returned 22.83% so far this year and 94.22% over the past 12 months.

Based on dividend-adjusted daily data since Oct 25, 2019, CABA's average daily return is +0.17%, while the average monthly return is +3.49%. At this rate, your investment would double in approximately 1.7 years.

Historically, 47% of months were positive and 53% were negative. The best month was Nov 2022 with a return of +165.1%, while the worst month was Dec 2021 at -67.3%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 8 months.

On a daily basis, CABA closed higher 46% of trading days. The best single day was Oct 20, 2022 with a return of +50.8%, while the worst single day was Dec 14, 2021 at -73.1%.

Cabaletta Bio, Inc. has an annualized alpha of 29.82%, beta of 1.21, and R² of 0.05 versus S&P 500 Index. Calculated based on daily prices since October 28, 2019.

• This stock participated in 203.95% of S&P 500 Index downside but only 135.99% of its upside — more exposed to losses than it benefited from rallies.
• R² of 0.05 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

CABA ranks 71 for risk / return — better than 71% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

The table below present risk-adjusted performance metrics for Cabaletta Bio, Inc. (CABA) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Cabaletta Bio, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Cabaletta Bio, Inc. was 96.63%, occurring on Sep 23, 2022. Recovery took 294 trading sessions.

The current Cabaletta Bio, Inc. drawdown is 89.40%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Cabaletta Bio, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Cabaletta Bio, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.